Living-Donor Liver Transplant Follow-Up: A Single Center Experience

被引:1
|
作者
Laeeq, Syed Mudassir [1 ]
Hanif, Farina M. [1 ]
Luck, Nasir Hassan [1 ]
Mandhwani, Rajesh Kumar [1 ]
Iqbal, Jawed [1 ]
Mehdi, Syed Haider [2 ]
机构
[1] Sindh Inst Urol & Transplantat, Dept Hepatogastroenterol, Karachi 74200, Pakistan
[2] Sindh Inst Urol & Transplantat, Dept Hepatobiliary Surg, Karachi, Pakistan
关键词
Anti-viral agents; Diabetes mellitus; Dyslipidemia; HCV; Hypertension; HEPATITIS-C VIRUS; RISK-FACTORS; HCV; SOFOSBUVIR; INFECTION; RIBAVIRIN;
D O I
10.6002/ect.mesot2016.P122
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Objectives: Liver transplant is a definite treatment of decompensated liver disease. Because of the shortage of livers from deceased donors, living-donor liver transplant is becoming more common. Here, we analyzed our clinical experience in the follow-up care of these patients. Materials and Methods: Liver transplant recipients seen at the Sindh Institute of Urology and Transplantation (Karachi, Pakistan) were included in this analysis. Baseline characteristics and follow-up events were recorded. Results: Our study population included 76 liver transplant patients registered at our clinic. Median age was 42 years, with 62 patients (81.6%) being males. The most common indication of transplant was hepatitis C virus-related cirrhosis (42 patients; 55%), followed by hepatitis B-hepatitis D virus coinfection (8 patients; 10.5%). Anastomotic biliary stricture developed in 16 patients (21.1%), which required biliary stenting. Biliary leak developed in 5 patients (6.6%), and renal cell carcinoma developed in 1 patient. Two recipients died due to hepatitis C virus-related fibrosing cholestasis hepatitis and pulmonary complications. Posttransplant diabetes mellitus developed in 36 (47.1%), hypertension in 17 (38.6%), and dyslipidemia in 19 patients (25%). Of 42 patients with hepatitis C virus infection, 26 were treated with pegylated interferon and ribavirin, of which 65.3% achieved sustained virologic response at 24 weeks. The other 16 patients received sofosbuvir combined with ribavirin for 24 weeks. A sustained virologic response at 12 weeks was achieved in 5 patients, with not yet determined results in the remaining patients. Seven patients were lost to follow-up. Conclusions: Hepatitis C-related cirrhosis was the most common indication for liver transplant, and infection recurrence was observed in our patients. Biliary anastomotic stricture formation was the most prevalent complication after transplant. As liver transplants are becoming more widely available for Pakistani patients at home and abroad, gastroenterologists and trainees in our country should be sensitized, educated, and skilled in the posttransplant care of these patients.
引用
收藏
页码:254 / 257
页数:4
相关论文
共 50 条
  • [31] Factors associated with immediate and early extubation in pediatric living-donor liver transplant recipients
    Saeyup, Pipat
    Paarporn, Paweena
    Prasarnphan, Daraneenuch
    Wongpiyaboworn, Wasipon
    PEDIATRIC ANESTHESIA, 2023, 33 (01) : 59 - 68
  • [32] Recurrent Hepatitis C Virus Infection and Outcome After Living-Donor Liver Transplant
    Satapathy, Sanjaya K.
    Fiel, Maria Isabel
    Vanatta, Jason M.
    Martin, Juan Del Rio
    Schiano, Thomas D.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2013, 11 (06) : 522 - 529
  • [33] Comparison of preemptive kidney transplant recipients with nonpreemptive kidney recipients in single center: 5 years of follow-up
    Sayin, Burak
    Colak, Turan
    Tutal, Emre
    Sezer, Siren
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2013, 6 : 95 - 99
  • [34] Prevalence of Postoperation Metabolic Syndrome in Pediatric Liver Transplant Patients: A Single Center Experience
    Vafaei, Farzad
    Dehghani, Seyed Mohsen
    Malekhoseini, Seyed Ali
    Karamifar, Hamdollah
    Nikeghbalian, Saman
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2018, 16 (05) : 582 - 587
  • [35] Use of the Right Lobe Graft With Double Hepatic Arteries in Living-Donor Liver Transplant
    Cakir, Tugrul
    Sabuncuoglu, M. Zafer
    Soyer, Vural
    Sarici, Baris
    Koc, Suleyman
    Onur, Asim
    Unal, Bulent
    Akbulut, Sami
    Yilmaz, Sezai
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (05) : 495 - 499
  • [36] Single-center experience of living donor liver transplantation in patients with portal vein thrombosis
    Song, Sanghyun
    Kwon, Choon Hyuck David
    Kim, Jong Man
    Joh, Jae-Won
    Lee, Suk-Koo
    CLINICAL TRANSPLANTATION, 2016, 30 (09) : 1146 - 1151
  • [37] Vascular Complications After Living Donor Liver Transplantation: A Brazilian, Single-Center Experience
    Steinbrueck, K.
    Enne, M.
    Fernandes, R.
    Martinho, J. M.
    Balbi, E.
    Agoglia, L.
    Roma, J.
    Pacheco-Moreira, L. F.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (01) : 196 - 198
  • [38] Transrenal fixation of aortic endografts: Intermediate follow-up of a single-center experience
    Lobato, AC
    Quick, RC
    Vaughn, PL
    Rodriguez-Lopez, J
    Douglas, M
    Diethrich, EB
    JOURNAL OF ENDOVASCULAR THERAPY, 2000, 7 (04) : 273 - 278
  • [39] Poor outcomes of early recurrent post-transplant bloodstream infection in living-donor liver transplant recipients
    Kim, Si-Ho
    Mun, Seok Jun
    Ko, Jae-Hoon
    Huh, Kyungmin
    Cho, Sun Young
    Kang, Cheol-In
    Chung, Doo Ryeon
    Choi, Gyu-Seong
    Kim, Jong Man
    Joh, Jae-Won
    Peck, Kyong Ran
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (04) : 771 - 778
  • [40] Living Donor Liver Transplantations in HIV- and Hepatitis C Virus-Coinfected Hemophiliacs: Experience in a Single Center
    Tsukada, Kunihisa
    Sugawara, Yasuhiko
    Kaneko, Junichi
    Tamura, Sumihito
    Tachikawa, Natsuo
    Morisawa, Yuji
    Okugawa, Shu
    Kikuchi, Yoshimi
    Oka, Shinichi
    Kimura, Satoshi
    Yatomi, Yutaka
    Makuuchi, Masatoshi
    Kokudo, Norihiro
    Koike, Kazuhiko
    TRANSPLANTATION, 2011, 91 (11) : 1261 - 1264